Northwest Biotherapeutics reported $-50.54M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agenus USD -199.08M 22.15M Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Celldex Therapeutics USD 714.56M 258.34M Jun/2026
Eisai JPY 906.56B 7.57B Jun/2026
Merck USD 41.93B 3.94B Jun/2026
Northwest Biotherapeutics USD -50.54M 58.1M Mar/2026
Pfizer USD 85.19B 4.91B Jun/2026
Plus Therapeutics USD 5.46M 6.5M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026